Cargando…
A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient
Triple-negative breast cancer (TNBC) is the most aggressive subtype of mammary carcinoma. Here, we describe a case of an 81-year-old female diagnosed with ductal triple negative breast cancer with a germline pathogenic variant in BReast CAncer gene2 (BRCA2). Genetic testing also revealed the presenc...
Autores principales: | Han, Yuyi, Rovella, Valentina, Smirnov, Artem, Buonomo, Oreste Claudio, Mauriello, Alessandro, Perretta, Tommaso, Shi, Yufang, Woodmsith, Jonathan, Bischof, Julia, Melino, Gerry, Candi, Eleonora, Bernassola, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562433/ https://www.ncbi.nlm.nih.gov/pubmed/37813891 http://dx.doi.org/10.1038/s41420-023-01651-3 |
Ejemplares similares
-
A primary luminal/HER2 negative breast cancer patient with mismatch repair deficiency
por: Yang, Xue, et al.
Publicado: (2023) -
p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancer
por: Cappello, Angela, et al.
Publicado: (2023) -
Distinct interactors define the p63 transcriptional signature in epithelial development or cancer
por: Pecorari, Rosalba, et al.
Publicado: (2022) -
Aged mesenchymal stem cells and inflammation: from pathology to potential therapeutic strategies
por: Yang, Xue, et al.
Publicado: (2023) -
Gene expression in organoids: an expanding horizon
por: Smirnov, Artem, et al.
Publicado: (2023)